First, buying of the stock has been going on for a year. If we look at the return of the stock, it is clear that the stock has increased by 3 percent in a week, 10 percent in three months and 40 percent in a year. The return of three years is more than 150 percent. This company is Torrent Pharmaceuticals Ltd. It is a leading pharmaceutical company of India, which mainly does R&D of generic medicines, active pharmaceutical ingredients (APIs), and biotechnology products.

Experts say that if FIIs are buying a stock, it means that foreign investors have faith in that company and they are seeing growth in it. This can increase the share price, market sentiment and sector value.

But trading should not be done only by looking at FII investment, but fundamental and technical analysis is also important. What does Torrent Pharmaceuticals Ltd do- The company specializes in generic medicines, APIs, and biotech products. It works in important medical categories such as cardiology, diabetes, neurology, and oncology and is expanding rapidly globally. Company started- In 1959. Headquarters: Ahmedabad, Gujarat. Founder is Utemchand Shah. FIIs continue to buy shares- Information released on the exchange states that FIIs are continuing to buy. In December 2023, FIIs had a 14.08 percent stake. In March 2024, it increased to 14.14 percent. In June 2024, it increased to 14.22 percent. After this, it increased to 14.46 percent in September and 16.17 percent in December. On the other hand, DII has also bought shares. The stake has increased from 7.21 percent to 8.35 percent in December 2024 as compared to December 2023. At the same time, it has increased from 7.08 percent to 8.35 percent in December 2024 as compared to September 2024. But the promoters have sold shares. It has fallen from 71.25 percent to 68.31 percent in December 2024 as compared to September 2024. What is Torrent Pharmaceuticals going to do next.   The company recently said that it will enter new therapeutic areas (oncology, immunology, rare diseases). Will expand in the international market (launch more products in the US and Europe). Will invest in new pharma innovation and R&D. It will focus more on biosimilars and specialty medicines. The second company  is Dixon Technologies Ltd - It is a leading Electronic Manufacturing Services (EMS) company in India. This company is in the business of manufacturing, designing and assembling electronics products. Dixon also does contract manufacturing for various domestic and global brands. The share price has increased by 150 percent in a year. It manufactures LED TVs, smartphones, laptops, home appliances, and security devices. It does OEM and ODM manufacturing for big companies like Samsung, Xiaomi, Motorola, Philips, and Havells. Under Make in India and PLI scheme, Dixon has a bright future and it is making a big contribution to India's electronics sector. FIIs continue to buy shares - Information released on the exchange states that FIIs continue to buy. In December 2023, FIIs had a 17.41 percent stake. In March 2024, it increased to 17.85 percent. In June 2024, it increased to 19.33 percent. After this, it increased to 22.69 percent in September and 23.22 percent in December. But the promoters have sold the shares.